Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
OFIX
ORTHOFIX MEDICAL INC.
NASDAQ
$9.20
▼ DOWN 2.23% (-0.21)

KEY STATISTICS

Market Cap$371.88 M
52w High$16.99
52w Low$8.50
Dividend Yield—
Frequency—
P/E-5.99
Volume394.36K
Shares Out.40.42M

COMPANY

LEADERSHIP

Massimo Calafiore
CHIEF EXECUTIVE
Massimo Calafiore

COMPENSATION 2026

Salary$848,322
Stock Awards$4,499,988
Incentive Plan Pay$445,579
All Other Comp.$16,141
Total$7,310,039

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 24, 1992
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
1,605

PRICE TARGET

Target High$15.00
Target Low$12.00
Target Median$13.00
Target Consensus$13.40

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$210.69M
NOV
3
TUE

ETFS HOLDING THIS STOCK

ETFS HOLDING
105
LISTED HERE
10
RANKED BY POSITION SIZE
VTI
0.00%
1.2M
IWM
0.01%
1.0M
DFAS
0.01%
213.9K
SCHA
0.01%
211.6K
FESM
0.02%
160.4K
XHE
0.53%
101.0K
BSVO
0.04%
89.5K
GSSC
0.06%
69.9K
AVSC
0.02%
69.5K
XSXD.SG
0.01%
50.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
69.68%
HOLDERS
232
TOP 8 OF 232 · RANKED BY POSITION SIZE
Engine Capital Management, LP
4.6M sh
$41.82M
Juniper Investment Company, LLC
4.4M sh
$40.6M
Rubric Capital Management LP
3.7M sh
$34.02M
Paradigm Capital Management Inc/Ny
3.3M sh
$48.96M
Blackrock, Inc.
3.3M sh
$30.4M
Armistice Capital, LLC
3.3M sh
$29.83M
Blackrock Inc.
3.2M sh
$42.26M
Vanguard Group Inc
2.3M sh
$34.94M

PRICE

$9.20 ▼ DOWN 2.23% (−$0.21)
$9.20$9.30$9.40$9.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM9.20

About Orthofix Medical Inc.

https://www.orthofix.com ↗

Orthofix Medical Inc. is a global medical device and biologics company specializing in spine and orthopedic products for bone healing, fusion, and reconstruction, serving healthcare providers worldwide.

INDUSTRY

Medical - Devices

A PRODUCT ORTHOFIX MEDICAL INC. IS KNOWN FOR

TrueLok Elevate Transverse Bone Transport System
TrueLok Elevate Transverse Bone Transport System

TrueLok Elevate is an advanced external fixation system by Orthofix for limb reconstruction, specifically designed for transverse bone transport to treat complex lower limb conditions like diabetic foot ulcers, helping reduce amputation risk.

COMPETITORS

COMPETITOR
GMED COMPARE
IART COMPARE
SNN COMPARE
SYK COMPARE
ZBH COMPARE

Orthofix Medical in 2025

SENTIMENT: − NEGATIVE
Julie Andrews
EARNINGS · NOVEMBER 2025

Orthofix Stock Drops After Reporting Significant Q3 2025 Earnings Miss, Overshadowing Revenue Beat

On November 4, 2025, Orthofix Medical Inc. announced its third-quarter financial results, revealing a mixed performance that captured investor attention. While the company exceeded revenue expectations with $203.4 million against a forecast of $200.26 million, it posted a significant earnings per share (EPS) loss of -$0.57, which was substantially worse than the anticipated -$0.33, resulting in a 72.73% negative surprise. The negative earnings report led to a pre-market stock price drop of 4.7%, reflecting investor concern over profitability despite the revenue growth.

PRODUCT DISCONTINUATION · FEBRUARY 2025 · IN PROGRESS

Orthofix Discontinues M6 Artificial Disc to Sharpen Focus on Profitable Core Spine Business

Orthofix made a strategic decision to discontinue its M6-C artificial cervical and M6-L artificial lumbar disc product lines to reallocate resources to more profitable growth areas. This move is a key part of a broader strategy to enhance focus on its core strengths in spinal fixation, deformity correction, and bone growth therapies, and is intended to improve long-term profitability and free cash flow.

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY Barrington Research OUTPERFORM Stifel BUY

SECTORS PEERS

PEERPRICE
BFLY$8.21COMPARE
ABSI$9.18COMPARE
MLTX$11.04COMPARE
SIBN$19.14COMPARE
PACB$2.68COMPARE
VREX$18.45COMPARE
LAB$0.73COMPARE
DRIO$6.14COMPARE

INSIDER TRADES

★
OFFICER: PRESIDENT, GLOBAL LIMB RECON
Fisher Patrick
Sale · 150 shares
2026-10-01
★
10 PERCENT OWNER
Juniper Investment Company, LLC
Purchase · 190.0K shares
2026-09-21
★
10 PERCENT OWNER
Juniper Investment Company, LLC
Purchase · 120.0K shares
2026-09-18
★
10 PERCENT OWNER
Juniper Investment Company, LLC
Sale · 190.0K shares
2026-09-21